Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18895554
[patent_doc_number] => 20240011039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/458752
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/458752 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Aug 29, 2023 | Issued |
Array
(
[id] => 18844911
[patent_doc_number] => 20230407315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/458744
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/458744 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Aug 29, 2023 | Issued |
Array
(
[id] => 18724330
[patent_doc_number] => 20230338468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 18/318566
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318566
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318566 | CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION | May 15, 2023 | Pending |
Array
(
[id] => 19089760
[patent_doc_number] => 11951179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Lipid nanoparticle compositions and methods for MRNA delivery
[patent_app_type] => utility
[patent_app_number] => 18/295150
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295150 | Lipid nanoparticle compositions and methods for MRNA delivery | Apr 2, 2023 | Issued |
Array
(
[id] => 18707680
[patent_doc_number] => 20230330262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/295159
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295159 | Lipid nanoparticle compositions and methods for mRNA delivery | Apr 2, 2023 | Issued |
Array
(
[id] => 19089761
[patent_doc_number] => 11951180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Lipid nanoparticle compositions and methods for MRNA delivery
[patent_app_type] => utility
[patent_app_number] => 18/295152
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295152 | Lipid nanoparticle compositions and methods for MRNA delivery | Apr 2, 2023 | Issued |
Array
(
[id] => 18647940
[patent_doc_number] => 20230293723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/295139
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295139 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY | Apr 2, 2023 | Abandoned |
Array
(
[id] => 18643480
[patent_doc_number] => 11767541
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-26
[patent_title] => Adeno-associated virus complex with improved expression of RUNX3 gene and uses for preventing or treating KRAS mutated lung cancer
[patent_app_type] => utility
[patent_app_number] => 18/190561
[patent_app_country] => US
[patent_app_date] => 2023-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9656
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18190561
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/190561 | Adeno-associated virus complex with improved expression of RUNX3 gene and uses for preventing or treating KRAS mutated lung cancer | Mar 26, 2023 | Issued |
Array
(
[id] => 18948335
[patent_doc_number] => 11891617
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-06
[patent_title] => Modified complex platform of adeno-associated virus with improved rate of expression of loaded genes and reduced genotoxicity
[patent_app_type] => utility
[patent_app_number] => 18/190630
[patent_app_country] => US
[patent_app_date] => 2023-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10450
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18190630
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/190630 | Modified complex platform of adeno-associated virus with improved rate of expression of loaded genes and reduced genotoxicity | Mar 26, 2023 | Issued |
Array
(
[id] => 19135777
[patent_doc_number] => 11970708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus
[patent_app_type] => utility
[patent_app_number] => 18/185656
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 40
[patent_no_of_words] => 13758
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185656 | Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus | Mar 16, 2023 | Issued |
Array
(
[id] => 18612701
[patent_doc_number] => 20230279435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS
AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/069701
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069701 | Adeno-associated virus variant capsids and methods of use thereof | Dec 20, 2022 | Issued |
Array
(
[id] => 18726155
[patent_doc_number] => 20230340411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/065580
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065580
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065580 | Gene-regulating compositions and methods for improved immunotherapy | Dec 12, 2022 | Issued |
Array
(
[id] => 18460402
[patent_doc_number] => 11684680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Synthetic DNA vectors and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/057032
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 45510
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057032 | Synthetic DNA vectors and methods of use | Nov 17, 2022 | Issued |
Array
(
[id] => 18567439
[patent_doc_number] => 20230257772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => ADENO-ASSOCIATED VARIANTS, FORMULATIONS AND METHODS FOR PULMONARY DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/938641
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938641
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938641 | Adeno-associated variants, formulations and methods for pulmonary delivery | Oct 5, 2022 | Issued |
Array
(
[id] => 18269044
[patent_doc_number] => 20230090286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/929647
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929647 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Sep 1, 2022 | Issued |
Array
(
[id] => 19166026
[patent_doc_number] => 11981916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => RNA-guided nucleases and active fragments and variants thereof and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/929165
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73755
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929165 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Aug 31, 2022 | Issued |
Array
(
[id] => 18909323
[patent_doc_number] => 11872286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Compositions and methods for delivery of nucleic acids to cells
[patent_app_type] => utility
[patent_app_number] => 17/823488
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 48
[patent_no_of_words] => 37410
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823488 | Compositions and methods for delivery of nucleic acids to cells | Aug 29, 2022 | Issued |
Array
(
[id] => 18886384
[patent_doc_number] => 11865140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Restimulation of cryopreserved tumor infiltrating lymphocytes
[patent_app_type] => utility
[patent_app_number] => 17/819910
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41845
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819910 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Aug 14, 2022 | Issued |
Array
(
[id] => 18164288
[patent_doc_number] => 20230030883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/819909
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819909 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | Aug 14, 2022 | Pending |
Array
(
[id] => 19150138
[patent_doc_number] => 11975028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Restimulation of cryopreserved tumor infiltrating lymphocytes
[patent_app_type] => utility
[patent_app_number] => 17/819219
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41956
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819219 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Aug 10, 2022 | Issued |